Patents by Inventor Noël Zakarian

Noël Zakarian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040137053
    Abstract: The invention relates to a method for preparing water-soluble granules containing at least one naturally poorly water-soluble or -insoluble antiseptic. The invention also relates to the use of said method, in particular for the preparation of pharmaceutical compositions in dry form which can be used to produce, extemporaneously, solutions for mouthwashes.
    Type: Application
    Filed: February 13, 2004
    Publication date: July 15, 2004
    Inventors: Dominique Toselli, Noel Zakarian
  • Patent number: 6669957
    Abstract: The invention relates to pharmaceutical dosage forms with rapid disintegration in the mouth and to their process of preparation. These pharmaceutical dosage forms comprise at least one active principle dispersed in a mixture of excipients and are characterized in that the mixture of excipients comprises at least one weakly compressible diluting agent other than trehalose and a copolymer of 1-vinylpyrrolidin-2-one and of vinyl acetate. Applications: oral administration of a great many active principles (analgesics, antispasmodics, agents used in gastroenterology, agents for combating motion sickness, antimigraines, &bgr;-blockers, antihistaminics, antibiotics or antibacterials, antivertigos, hypnotics, and the like).
    Type: Grant
    Filed: September 5, 2001
    Date of Patent: December 30, 2003
    Assignee: CLL Pharma
    Inventors: Claude Laruelle, Noël Zakarian, René Gimet, Dominique Toselli
  • Patent number: 6605301
    Abstract: The invention relates to dispersible tablets containing macrolides as active ingredients either on their own or associated with other active ingredients, in addition to a method for the production thereof. The dispersible tablets are characterized in that the macrolide is chosen from a group that is made up of pristinamycin, azithromycin, roxithromycin, clarithromycin and spiramycin, and is present in a basic form in proportions ranging from 20-60% of the total weight of said tablets. The dispersible tablets are also characterized in that they contain at least one disintegrator in proportions ranging from 1-25% of the total weight of said tablets in addition to at least one sweetening agent.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: August 12, 2003
    Assignee: CCL Pharma
    Inventors: Noël Zakarian, René Gimet, Claude Laruelle, Dominique Toselli
  • Publication number: 20020061333
    Abstract: The invention relates to dispersible tablets containing macrolides as active ingredients either on their own or associated with other active ingredients, in addition to a method for the production thereof. The dispersible tablets are characterized in that the macrolide is chosen from a group that is made up of pristinamycin, azithromycin, roxithromycin, clarithromycin and spiramycin, and is present in a basic form in proportions ranging from 20-60% of the total weight of said tablets. The dispersible tablets are also characterized in that they contain at least one disintegrator in proportions ranging from 1-25% of the total weight of said tablets in addition to at least one sweetening agent.
    Type: Application
    Filed: September 28, 2001
    Publication date: May 23, 2002
    Inventors: Noel Zakarian, Rene Gimet, Claude Laruelle, Dominique Toselli